Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Humanin's Value for Early Diagnosis and Short-term Prognosis in Patients With AKI After Heart Transplantation

NCT06125249 is registered in ClinicalTrials.gov with Li zhilian as lead sponsor.

NCT NCT06125249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06125249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Humanin's Value for Early Diagnosis and Short-term Prognosis in Patients With AKI After Heart Transplantation
Lead sponsor
Li zhilian
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
June 30, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, heart transplant surgery